Wenyan J. Zhang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Insights into Langerhans cell sarcoma: Focus on cutaneous Langerhans cell sarcoma.
Journal: Histopathology
Published: October 15, 2025
Case Report: diffuse entire gastrointestinal tract involvement of ALK-positive anaplastic large cell lymphoma harboring JAK-STAT pathway mutations in an adolescent with leukemoid reaction.
Journal: Frontiers in oncology
Published: October 01, 2025
Chimeric antigen receptor T-cell therapy for relapsed/refractory primary cutaneous B-lymphoblastic lymphoma with rapid and durable systemic regression.
Journal: The British journal of dermatology
Published: July 29, 2025
Chronic Active Epstein-Barr Virus Myopathy Mimicking Idiopathic Inflammatory Myopathies: A Diagnostic Pitfall, Differentiating Features, and Clinical Impact Revealed in the 10-year Case Series.
Journal: Journal of medical virology
Published: July 08, 2025
How do drivers react to crossing pedestrians at unsignalized roads? A contrast study for naturalistic driving and dummy pedestrian test.
Journal: Scientific reports
Published: June 03, 2025
Intravascular large B-cell lymphoma as a covert trigger for hemophagocytic lymphohistiocytosis complicated with capillary leak syndrome: a case report and literature review.
Journal: Frontiers in immunology
Published: March 19, 2024
High CD8+tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma.
Journal: Frontiers in immunology
Published: May 24, 2023
Chromatin accessibility dynamics insight into crosstalk between regulatory landscapes in poplar responses to multiple treatments.
Journal: Tree physiology
Published: December 09, 2022
Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies.
Journal: American journal of clinical pathology
Published: August 20, 2022
Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment.
Journal: Frontiers in immunology
Published: July 05, 2022
Last Updated: 09/26/2026